51
$10M$50M
26$10M$50M
201$10M$50M
11La Jolla Pharmaceutical Company uses 8 technology products and services including Fastly, Amazon CloudFront, Amazon S3, and more. Explore La Jolla Pharmaceutical Company's tech stack below.
| La Jolla Pharmaceutical Company Email Formats | Percentage |
| FLast@ljpc.com | 85% |
| First.Last@ljpc.com | 3% |
| Last.First@ljpc.com | 2% |
| LastFir@ljpc.com | 1% |
| FirLast@ljpc.com | 2% |
| First-Last@ljpc.com | 1% |
| FirstLast@ljpc.com | 1% |
| LastFirst@ljpc.com | 1% |
| FirstL@ljpc.com | 1% |
| LastF@ljpc.com | 1% |
| L.First@ljpc.com | 1% |
| First_Last@ljpc.com | 1% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
Company Overview
Media & News
Funding & FinancialsLa Jolla Pharmaceutical Company has raised a total of $111M of funding over 4 rounds. Their latest funding round was raised on Sep 09, 2015 in the amount of $111M.
La Jolla Pharmaceutical Company's revenue is in the range of $10M$50M
Funding & FinancialsLa Jolla Pharmaceutical Company has raised a total of $111M of funding over 4 rounds. Their latest funding round was raised on Sep 09, 2015 in the amount of $111M.
La Jolla Pharmaceutical Company's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com